Schmitt, Niclas http://orcid.org/0000-0003-2509-5459
Weyland, Charlotte S. http://orcid.org/0000-0002-1374-7854
Wucherpfennig, Lena http://orcid.org/0000-0002-2280-1269
Herweh, Christian http://orcid.org/0000-0002-9223-9662
Bendszus, Martin http://orcid.org/0000-0002-9094-6769
Möhlenbruch, Markus A. http://orcid.org/0000-0002-5075-704X
Vollherbst, Dominik F. http://orcid.org/0000-0002-8992-4757
Funding for this research was provided by:
Siemens Healthineers (500 Euro (expense allowance) was paid to the institution)
Universitätsklinikum Heidelberg
Article History
Received: 27 April 2021
Accepted: 9 September 2021
First Online: 13 October 2021
Declarations
:
: N. Schmitt, C. S. Weyland and L. Wucherpfennig declare that they have no competing interests. C. Herweh consultancy fees from Brainomix. M. Bendszus reports board membership: DSMB Vascular Dynamics; consultancy: Roche, Guerbet, Codman; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, Covidien; payment for lectures (including service on speakers bureaus): Novartis, Roche, Guerbet, Teva, Bayer, Codman. M. A. Möhlenbruch has received consulting fees, speaker fees, and travel support outside this work from Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker. D. F. Vollherbst has received travel support outside this work from MicroVention, Stryker and Cerenovus.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.